Transamerica Financial Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.4K | Buy |
99
+49
| +98% | +$9.37K | ﹤0.01% | 865 |
|
|
2026
Q1 | $9.17K | Buy |
50
+33
| +194% | +$6.08K | ﹤0.01% | 939 |
|
|
2025
Q4 | $2.94K | Sell |
17
-2
| -11% | -$327 | ﹤0.01% | 1058 |
|
|
2025
Q3 | $2.66K | Buy |
+19
| New | +$2.57K | ﹤0.01% | 993 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$1K | – | 606 |
|
|
2023
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 390 |
|
|
2023
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 416 |
|
|
2023
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 388 |
|
|
2023
Q1 | $1K | Buy |
+1
| New | +$277 | ﹤0.01% | 383 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$1K | – | 654 |
|
|
2022
Q2 | $1K | Buy |
+1
| New | +$204 | ﹤0.01% | 413 |
|
|
2021
Q2 | – | Sell |
-6
| Closed | -$2K | – | 207 |
|
|
2021
Q1 | $2K | Buy |
6
+2
| +50% | +$539 | 0.05% | 68 |
|
|
2020
Q4 | $1K | Sell |
4
-1
| -20% | -$258 | 0.02% | 117 |
|
|
2020
Q3 | $2K | Sell |
5
-1,048
| -100% | -$292K | 0.04% | 70 |
|
|
2020
Q2 | $282K | Buy |
1,053
+1,049
| +26,225% | +$315K | 0.06% | 132 |
|
|
2020
Q1 | $2K | Sell |
4
-1
| -20% | -$303 | 0.04% | 56 |
|
|
2019
Q4 | $2K | Hold |
5
| – | – | 0.03% | 55 |
|
|
2019
Q3 | $2K | Sell |
5
-824
| -99% | -$192K | 0.03% | 53 |
|
|
2019
Q2 | $194K | Buy |
829
+826
| +27,533% | +$191K | 0.04% | 164 |
|
|
2019
Q1 | $1K | Sell |
3
-796
| -100% | -$251K | 0.01% | 71 |
|
|
2018
Q4 | $241K | Sell |
799
-247
| -24% | -$78.8K | 0.06% | 149 |
|
|
2018
Q3 | $370K | Sell |
1,046
-60
| -5% | -$20.7K | 0.08% | 149 |
|
|
2018
Q2 | $321K | Sell |
1,106
-9,166
| -89% | -$2.58M | 0.07% | 152 |
|
|
2018
Q1 | $2.81M | Buy |
10,272
+490
| +5% | +$152K | 0.42% | 83 |
|
|
2017
Q4 | $3.12M | Buy |
9,782
+9,778
| +244,450% | +$3.14M | 0.41% | 79 |
|
|
2017
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 306 |
|
|
2017
Q2 | $1K | Buy |
4
+1
| +33% | +$264 | ﹤0.01% | 295 |
|
|
2017
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 292 |
|
|
2016
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 324 |
|
|
2016
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 337 |
|
|
2016
Q2 | $1K | Buy |
+3
| New | +$791 | ﹤0.01% | 299 |
|
|
2015
Q2 | – | Sell |
-16
| Closed | -$7K | – | 897 |
|
|
2015
Q1 | $7K | Sell |
16
-995
| -98% | -$392K | ﹤0.01% | 658 |
|
|
2014
Q4 | $344K | Buy |
+1,011
| New | +$327K | 0.03% | 236 |
|
|
2014
Q2 | – | Sell |
-1,250
| Closed | -$383K | – | 697 |
|
|
2014
Q1 | $383K | Buy |
1,250
+401
| +47% | +$127K | 0.04% | 181 |
|
|
2013
Q4 | $238K | Buy |
+849
| New | +$220K | 0.03% | 236 |
|
Other funds holding BIIB
Transamerica Financial Advisors's BIIB Position: Q2 2026 in Review
Transamerica Financial Advisors increased its Biogen (BIIB) stake by 98% in Q2 2026, buying an estimated $9.37K and bringing the position to 99 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #865.
Transamerica Financial Advisors first reported a position in BIIB in Q4 2013 and has held it in 33 quarters since. The position peaked at $3.12M in Q4 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Transamerica Financial Advisors held 99 shares of Biogen worth $21.4K as of Q2 2026.
- Transamerica Financial Advisors bought 49 Biogen shares in Q2 2026, an estimated $9.37K.
- Biogen made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #865 holding.
- Transamerica Financial Advisors first reported a position in Biogen in Q4 2013 and has held it in 33 quarters since.
- Transamerica Financial Advisors's Biogen position peaked at $3.12M in Q4 2017.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.